logo-loader
Inchcape

Inchcape jumps 5% as French broker Exane BNP Paribas returns rating to 'outperform'

Exane has also increased its target price for the FTSE250-listed group to 1,050p, up from 735p previously, offering 30% upside potential

shutterstock_418121527_58d8d45bc5d58.jpg
In early morning trading, Inchcape shares were 40.5p higher at 845.5p

Bullish comment from French broker Exane BNP Paribas drove a 5% gain in the shares of global motor dealer Inchcape PLC (LON:INCH) this morning.

Exane has upgraded its stance for the FTSE 250-listed group to ‘outperform’ from ‘neutral’, with an increased target price of 1,050p, up from 735p previously, offering 30% upside potential.

In early morning trading, Inchcape shares were 40.5p higher at 845.5p.

In a note to clients, Exane’s analysts said Inchcape’s Ignite strategy is “beginning to bear fruit and underpins double digit EPS growth over the next  four years.”

They added: “Growth is moving from new vehicle sales to aftersales, self-help and M&A; broadening  the global presence and quality of the business.”

The analysts noted:  “The investment case has undergone a sharp U-turn over the past 6 months.

“The macro backdrop has improved and there would now look to be upside risk to the demand environment. Currency has turned from a headwind to tailwind.”

They added: “The relevance of the macro and structurally challenged UK retail sector to Inchcape is diminishing.” 

Quick facts: Inchcape

Price: £6.41

Market: LSE
Market Cap: £2.59 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

2 days, 10 hours ago

RNS

Transaction in Own Shares

2 days, 10 hours ago

Transaction in Own Shares

3 days, 9 hours ago

Transaction in Own Shares

4 days, 10 hours ago

Transaction in Own Shares

5 days, 10 hours ago

Transaction in Own Shares

6 days, 10 hours ago

Transaction in Own Shares

1 week, 3 days ago

Transaction in Own Shares

1 week, 4 days ago

2 min read